Editorial: Negative impact of diabetes mellitus and obesity on the prognosis of patients with chronic liver disease

Editorial: Negative impact of diabetes mellitus and obesity on the prognosis of patients with chronic liver disease—Authors' reply

Published:2023-09-28 Issue:8 Volume:58 Page:826-827
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Paternostro Rafael¹²^ORCID,Jachs Mathias¹²^ORCID,Reiberger Thomas¹²³^ORCID,Mandorfer Mattias¹²^ORCID

Affiliation:

1. Divison of Gastroenterology and Hepatology, Department of Internal Medicine III Medical University of Vienna Vienna Austria

2. Vienna Hepatic Hemodynamic Laboratory, Division of Gastroenterology and Hepatology, Department of Internal Medicine III Medical University of Vienna Vienna Austria

3. Christian Doppler Laboratory for Portal Hypertension and Liver Fibrosis Medical University of Vienna Vienna Austria

Abstract

LINKED CONTENTThis article is linked to Paternostro et al papers. To view these articles, visithttps://doi.org/10.1111/apt.17653andhttps://doi.org/10.1111/apt.17673

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17686

Reference9 articles.

1. Editorial: negative impact of diabetes mellitus and obesity on the prognosis of patients with chronic liver disease;Llop E;Aliment Pharmacol Ther,2023

2. Diabetes impairs the haemodynamic response to non‐selective betablockers in compensated cirrhosis and predisposes to hepatic decompensation;Paternostro R;Aliment Pharmacol Ther,2023

3. β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial

4. Baveno VII – Renewing consensus in portal hypertension

5. Hepatic Venous Pressure Gradient Response in Non-Selective Beta-Blocker Treatment—Is It Worth Measuring?